Seres Therapeutics, Inc.MCRBNASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank31
3Y CAGR-19.2%
5Y CAGR-4.8%
Year-over-Year Change
Total of all costs and expenses
3Y CAGR
-19.2%/yr
vs +8.8%/yr prior
5Y CAGR
-4.8%/yr
Recent deceleration
Acceleration
-28.0pp
Decelerating
Percentile
P31
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $94.76M | -21.9% |
| 2024 | $121.31M | -37.8% |
| 2023 | $195.10M | +8.4% |
| 2022 | $179.91M | -14.1% |
| 2021 | $209.42M | +72.6% |
| 2020 | $121.34M | +14.1% |
| 2019 | $106.38M | -17.2% |
| 2018 | $128.55M | +4.1% |
| 2017 | $123.50M | +7.8% |
| 2016 | $114.61M | - |